Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 11.95
+0.10 (0.84%)
Aug 19, 2026, 1:27 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 6.91 billion as of August 18, 2026. Its market cap has decreased by -24.33% in one year.
Market Cap
6.91B
Enterprise Value
3.71B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
11.95
ChartMarket Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 6.91B, a decrease of -69.87%. That is a compound annual growth rate of -32.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 6.91B | -22.71% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 9.29B |
| TCM Biotech International | 8.80B |
| PharmaEngine | 8.49B |
| Locus Cell | 7.60B |
| Adimmune | 7.27B |
| Savior Lifetec | 6.43B |
| TaiGen Biopharmaceuticals Holdings | 6.18B |
| Sinphar Pharmaceutical | 6.02B |